These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 712981)

  • 1. Megavitamins for minimal brain dysfunction. A placebo-controlled study.
    Arnold LE; Christopher J; Huestis RD; Smeltzer DJ
    JAMA; 1978 Dec; 240(24):2642-3. PubMed ID: 712981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of megavitamin therapy on children with attention deficit disorders.
    Haslam RH; Dalby JT; Rademaker AW
    Pediatrics; 1984 Jul; 74(1):103-11. PubMed ID: 6234505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megavitamins for minimal brain dysfunction. A potentially dangerous therapy.
    Shaywitz BA; Siegel NJ; Pearson HA
    JAMA; 1977 Oct; 238(16):1749-50. PubMed ID: 578271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of megadoses of selected B complex vitamins on children with hyperkinesis: controlled studies with long-term follow-up.
    Brenner A
    J Learn Disabil; 1982 May; 15(5):258-64. PubMed ID: 7086283
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral disorders, learning disabilities and megavitamin therapy.
    LaPerchia P
    Adolescence; 1987; 22(87):729-38. PubMed ID: 2963502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.
    Lyon MR; Kapoor MP; Juneja LR
    Altern Med Rev; 2011 Dec; 16(4):348-54. PubMed ID: 22214254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal brain dysfunction and methylphenidate.
    Schwartz ML; Pizzo SV; McKee PA
    N Engl J Med; 1971 Jul; 285(5):293. PubMed ID: 5090403
    [No Abstract]   [Full Text] [Related]  

  • 8. Megavitamin and orthomolecular therapy in psychiatry.
    Nutr Rev; 1974 Jul; 32(0):suppl 1:44-7. PubMed ID: 4367658
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a role for megavitamin therapy in the treatment of attention deficit hyperactivity disorder?
    Haslam RH
    Adv Neurol; 1992; 58():303-10. PubMed ID: 1414636
    [No Abstract]   [Full Text] [Related]  

  • 10. Megavitamins and the hyperactive child.
    Nutr Rev; 1985 Apr; 43(4):105-7. PubMed ID: 3889726
    [No Abstract]   [Full Text] [Related]  

  • 11. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 13. Megavitamins and learning disorders: a controlled double-blind experiment.
    Kershner J; Hawke W
    J Nutr; 1979 May; 109(5):819-26. PubMed ID: 374692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial.
    Vaughan K; McConaghy N
    Aust N Z J Psychiatry; 1999 Feb; 33(1):84-8. PubMed ID: 10197889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Observations on some clinical results obtained by means of the combined use of an adrenal cortex extract and vitamin].
    Tezzele A
    Gazz Med Ital; 1965 Jul; 124(7):225-7. PubMed ID: 5833979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pantogam augmentation in hyperkinetic behavior disorder treatment].
    Kupriyanova TA; Koren EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):66-69. PubMed ID: 27456906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The learning-disabled or hyperactive child: diagnosis and treatment.
    Sulzbacher SI
    JAMA; 1975 Dec; 234(9):938-41. PubMed ID: 1242491
    [No Abstract]   [Full Text] [Related]  

  • 20. Food allergy in children with hyperactivity, learning disabilities and/or minimal brain dysfunction.
    Tryphonas H; Trites R
    Ann Allergy; 1979 Jan; 42(1):22-7. PubMed ID: 760622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.